Indications of tonsillectomy
Reading File
Finding Sources
Searching PubMed
tonsillectomy indications guidelines
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive information from multiple authoritative ENT textbooks. Here is a complete summary:
Indications for Tonsillectomy
Absolute Indications
| Category | Details |
|---|---|
| Obstructive Sleep Apnea / SDB | Tonsillar hypertrophy causing obstructive sleep-disordered breathing leading to adverse pulmonary or cardiovascular consequences (cor pulmonale, pulmonary hypertension) |
| Craniofacial/Dental effects | Hypertrophy causing malformation of facial bones or dental malocclusion |
| Dysphagia / Failure to thrive | Marked hypertrophy resulting in dysphagia and poor weight gain (especially in children) |
| Recurrent peritonsillar abscess | Recurrent abscesses requiring drainage that fail to resolve with appropriate antibiotics |
| Febrile convulsions | Tonsillitis precipitating febrile seizures |
| Suspected malignancy | Unilateral tonsillar enlargement or asymmetry suspicious for neoplasia; tonsillectomy for biopsy/exclusion or to search for unknown primary in head and neck cancer |
Relative Indications (Paradise/AAO Criteria)
The most widely used frequency thresholds for recurrent tonsillitis are:
- ≥7 episodes in the preceding year, OR
- ≥5 episodes/year for 2 consecutive years, OR
- ≥3 episodes/year for 3 consecutive years
- Episodes must be documented, clinically significant, and cause lost time from school/work requiring treatment by a clinician
- (Some clinicians use >2 weeks of school missed annually as an alternative threshold)
Additional Relative Indications
- Halitosis / foul taste — Persistent, not responding to medical therapy (due to tonsillar crypts/debris)
- Streptococcal carrier state — Chronic tonsillitis in a strep carrier failing beta-lactamase-resistant antibiotics
- Nocturnal enuresis — With coexistent upper airway obstructive sleep disorder from tonsillar/adenoid hypertrophy
- ADHD refractory to treatment — With coexistent obstructive sleep disorder
- Diphtheria carrier state
- Early-stage oropharyngeal cancer — Transoral robotic surgery (TORS)-assisted tonsillectomy
Adenotonsillectomy for OSA — Key Evidence
- First-line therapy for OSA/SDB in otherwise healthy children is adenotonsillectomy
- The CHAT trial (n=464, ages 5–9) showed 79% of surgical patients achieved AHI <2 vs. 46% in watchful waiting at 7 months (P <0.001)
- Overall "cure" rate (AHI <1–5) is approximately 66% (meta-analysis, Friedman et al.); lower in obese children, those >7 years, severe OSA
Contraindications
- Poor anesthetic risk
- Uncontrolled systemic illness
- Anemia
- Acute bilateral tonsillar infection (relative — surgery deferred until resolved)
- Anticoagulation or coagulopathy (must be reversed or specialist consulted)
Morbidity Reference
- Postoperative hemorrhage: 2–4% (primary <24 h; secondary at 5–7 days when eschar separates)
- Mortality: approximately 1 in 25,000 (causes: hemorrhage, airway obstruction, anesthesia)
Sources: K.J. Lee's Essential Otolaryngology; Pfenninger & Fowler's Procedures for Primary Care, 3e; Cummings Otolaryngology Head and Neck Surgery
This is a shared conversation. Sign in to Orris to start your own chat.